Literature DB >> 8924898

Enhancing effects of agelasphin-11 on natural killer cell activities of normal and tumor-bearing mice.

E Kobayashi1, K Motoki, T Natori, T Uchida, H Fukushima, Y Koezuka.   

Abstract

Agelasphin-11 (AGL-11), a novel alpha-galactosylceramide isolated from an extract of a marine sponge, Agelas mauritianus, markedly prolonged the life span of mice intraperitoneally inoculated with B16 cells. Since AGL-11 did not show any direct cytotoxic activity against B16 cells, this compound is considered to be a biological response modifier (BRM). We focused on the enhancing effect of this compound on in vivo natural killer (NK) cell activity because several BRMs have already been determined to enhance the in vivo natural killer (NK) cell activity. When we evaluated the enhancing activity of AGL-11 using normal mice, AGL-11 enhanced in vivo NK cell activity more potently than Poly I:C, which is a positive control. In addition, we examined the effect of this compound on the NK cell activity of tumor-bearing mice, and found that AGL-11 recovers the reduced NK cell activity in a tumor-bearing condition to a higher level than that of normal mice. These results suggest that AGL-11 shows antitumor activity by the activation of antitumor effector cells such as NK cells.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8924898     DOI: 10.1248/bpb.19.350

Source DB:  PubMed          Journal:  Biol Pharm Bull        ISSN: 0918-6158            Impact factor:   2.233


  5 in total

1.  α-Galactosylceramide protects mice from lethal Coxsackievirus B3 infection and subsequent myocarditis.

Authors:  C Y Wu; Y Feng; G C Qian; J H Wu; J Luo; Y Wang; G J Chen; X K Guo; Z J Wang
Journal:  Clin Exp Immunol       Date:  2010-08-19       Impact factor: 4.330

2.  Host immunomodulatory lipids created by symbionts from dietary amino acids.

Authors:  Sungwhan F Oh; T Praveena; Heebum Song; Ji-Sun Yoo; Da-Jung Jung; Deniz Erturk-Hasdemir; Yoon Soo Hwang; ChangWon C Lee; Jérôme Le Nours; Hyunsoo Kim; Jesang Lee; Richard S Blumberg; Jamie Rossjohn; Seung Bum Park; Dennis L Kasper
Journal:  Nature       Date:  2021-11-10       Impact factor: 49.962

3.  Tracking the response of natural killer T cells to a glycolipid antigen using CD1d tetramers.

Authors:  J L Matsuda; O V Naidenko; L Gapin; T Nakayama; M Taniguchi; C R Wang; Y Koezuka; M Kronenberg
Journal:  J Exp Med       Date:  2000-09-04       Impact factor: 14.307

4.  Agelasine D suppresses RANKL-induced osteoclastogenesis via down-regulation of c-Fos, NFATc1 and NF-κB.

Authors:  Moo Rim Kang; Sun Ah Jo; Yeo Dae Yoon; Ki Hwan Park; Soo Jin Oh; Jieun Yun; Chang Woo Lee; Ki-Hoan Nam; Youngsoo Kim; Sang-Bae Han; Jiyeon Yu; Jaerang Rho; Jong Soon Kang
Journal:  Mar Drugs       Date:  2014-11-24       Impact factor: 5.118

Review 5.  From Seabed to Bedside: A Review on Promising Marine Anticancer Compounds.

Authors:  Edina Wang; Maria Alba Sorolla; Priya Darshini Gopal Krishnan; Anabel Sorolla
Journal:  Biomolecules       Date:  2020-02-06
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.